Artiva Investigational Site Statesville — Statesville, North Carolina

Artiva Investigational Site Statesville is a clinical research site located in Statesville, North Carolina, United States 27103.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Artiva Investigational Site Statesville has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Refractory Rheumatoid Arthritis (RA), Idiopathic Inflammatory Myopathies (IIMs), Systemic Sclerosis (SSc).

Sponsors: Artiva Biotherapeutics, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Statesville

Browse all research sites in North Carolina · View every site in Statesville

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Artiva Investigational Site Statesville?

Artiva Investigational Site Statesville has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Artiva Investigational Site Statesville conducted?

Artiva Investigational Site Statesville has 1 clinical trials on record, with 1 currently active. Their work covers Refractory Rheumatoid Arthritis (RA), Idiopathic Inflammatory Myopathies (IIMs), Systemic Sclerosis (SSc).

Is Artiva Investigational Site Statesville accredited by Crixeo Clinical Trials?

Artiva Investigational Site Statesville has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Artiva Investigational Site Statesville?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.